Quantitative prediction of intestinal metabolism in humans from a simplified intestinal availability model and empirical scaling factor

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Keitaro KadonoToshio Teramura


This study aimed to establish a practical and convenient method of predicting intestinal availability (F(g)) in humans for highly permeable compounds at the drug discovery stage, with a focus on CYP3A4-mediated metabolism. We constructed a "simplified F(g) model," described using only metabolic parameters, assuming that passive diffusion is dominant when permeability is high and that the effect of transporters in epithelial cells is negligible. Five substrates for CYP3A4 (alprazolam, amlodipine, clonazepam, midazolam, and nifedipine) and four for both CYP3A4 and P-glycoprotein (P-gp) (nicardipine, quinidine, tacrolimus, and verapamil) were used as model compounds. Observed fraction of drug absorbed (F(a)F(g)) values for these compounds were calculated from in vivo pharmacokinetic (PK) parameters, whereas in vitro intestinal intrinsic clearance (CL(int,intestine)) was determined using human intestinal microsomes. The CL(int,intestine) for the model compounds corrected with that of midazolam was defined as CL(m,index) and incorporated into a simplified F(g) model with empirical scaling factor. Regardless of whether the compound was a P-gp substrate, the F(a)F(g) could be reasonably fitted by the simplified F(g) model, and the val...Continue Reading


Apr 20, 1977·European Journal of Clinical Pharmacology·M D RawlinsA R Hijab
Apr 1, 1984·British Journal of Clinical Pharmacology·M EichelbaumB Vogelgesang
Feb 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·A RakhitS Riegelman
Apr 1, 1982·Clinical Pharmacology and Therapeutics·R G McAllister, E B Kirsten
Nov 1, 1981·Journal of Pharmacobio-dynamics·K YamaokaT Uno
Jun 1, 1980·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S Higuchi, Y Shiobara
Jul 1, 1995·Clinical Pharmacology and Therapeutics·H H KupferschmidtS Krähenbühl
Jul 1, 1993·Pharmaceutical Research·B Davies, T Morris
May 1, 1996·Clinical Pharmacology and Therapeutics·K E ThummelG R Wilkinson
Jul 1, 1997·Clinical Pharmacology and Therapeutics·L C FlorenM F Hebert
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Z BenetV J Wacher
Mar 22, 2001·Advanced Drug Delivery Reviews·V J WacherL Z Benet
May 15, 2002·European Journal of Medicinal Chemistry·Chengyue ZhuKin-Kai Hwang
Apr 2, 2003·European Journal of Medicinal Chemistry·Yuan H ZhaoIan Cooper
Jun 30, 2005·Journal of Pharmaceutical Sciences·Manthena V S Varma, Ramesh Panchagnula
Feb 10, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mary F PaineDarryl C Zeldin
Jun 10, 2006·The Journal of Pharmacology and Experimental Therapeutics·Aleksandra Galetin, J Brian Houston
Nov 6, 2007·Current Drug Metabolism·Jiansong YangAmin Rostami-Hodjegan
Feb 21, 2009·Journal of Pharmaceutical Sciences·Masayuki TakahashiShinji Yamashita
Nov 17, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takafumi AkabaneToshio Teramura

❮ Previous
Next ❯


Apr 30, 2010·Pharmaceutical Research·Cuyue Tang, Thomayant Prueksaritanont
Sep 28, 2013·Pharmaceutical Research·Andrés Olivares-MoralesAmin Rostami-Hodjegan
Sep 1, 2011·Drug Metabolism and Pharmacokinetics·Haruka NishimutaSetsuko Komuro
Oct 6, 2011·Drug Metabolism and Pharmacokinetics·Takako FurukawaToshio Teramura
Mar 16, 2011·Journal of Biomedicine & Biotechnology·Offie P SoldinDonald R Mattison
Sep 22, 2010·Annual Review of Pharmacology and Toxicology·Malcolm RowlandGeoffrey Tucker
Jan 15, 2013·Journal of Pharmaceutical Sciences·Johan Bylund, Tjerk Bueters
Feb 22, 2011·Bioorganic & Medicinal Chemistry Letters·Phillip M CowleyGrant Wishart
Aug 22, 2013·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Takako FurukawaToshio Teramura
Dec 18, 2013·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Keitaro KadonoToshio Teramura
Jan 3, 2013·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Tjerk BuetersJohan Bylund
May 1, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Takako FurukawaToshio Teramura
Mar 12, 2015·Drug Metabolism and Pharmacokinetics·Yoichi NaritomiKenji Tabata
Feb 6, 2017·Biopharmaceutics & Drug Disposition·Estelle YauSheila Annie Peters
Jun 12, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Fumihiro NakamoriToshio Teramura
Aug 7, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Fredrik H KarlssonSheila Annie Peters
Jun 8, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Keigo KosakaToshiyuki Kume
Nov 22, 2018·Frontiers in Physiology·Pablo Torres-VergaraJeffrey Penny

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.